Viaminate
CAS: 53839-71-7
Ref. 3D-DCA83971
| 1g | Discontinued | ||
| 5g | Discontinued | ||
| 10g | Discontinued | ||
| 250mg | Discontinued | ||
| 500mg | Discontinued |
Product Information
Name:
Viaminate
Synonyms:
- N-(4-Ethoxycarbophenyl)retinamide
- N-(p-Ethoxycarbonylphenyl)retinamide
- N-[4-(Ethoxycarbonyl)phenyl]retinamide
- Retinamide, N-[4-(ethoxycarbonyl)phenyl]-
Description:
Viaminate is a small-molecule drug that targets the symptoms of squamous cell carcinoma. It has been shown to be effective against solid tumours, including squamous cell carcinomas, and is an antagonist of TNF-α. Viaminate inhibits the growth of tumor cells by binding to their receptors for epidermal growth factor (EGF) and transforming growth factor alpha (TGF-α). It also suppresses the production of TNF-α. This compound has been shown to inhibit tumor cells in vitro and in vivo, with no significant side effects.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
447.61 g/mol
Formula:
C29H37NO3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
